Literature DB >> 30290451

Genetic susceptibility in pituitary adenomas: from pathogenesis to clinical implications.

Marie-Lise Jaffrain-Rea1,2,3, Adrian F Daly4, Mariolina Angelini1, Patrick Petrossians4, Vincent Bours4, Albert Beckers4,5.   

Abstract

Pituitary adenomas usually present sporadically, with a multifactorial pathogenesis including somatic mutational events in cancer-related genes. Genetic predisposition implies the presence of germline DNA alterations with a range of impacts on pituitary cell biology, translating into a variable penetrance of the disease. Genetic causes must be considered in the presence of specific clinical settings, such as familial occurrence of pituitary adenoma, with or without extrapituitary diseases, and may also be suspected in young patients (<30 years of age) with macroadenomas. We review the clinical implications of genetic predisposition, with special attention on multiple endocrine neoplasia type 1, Carney complex and familial isolated pituitary adenoma. Genetic screening in selected patients with an apparently sporadic disease is also discussed.

Entities:  

Keywords:  AIP; Carney complex; FIPA; MEN1; McCune–Albright syndrome; aryl hydrocarbon receptor-interacting protein; familial isolated pituitary adenomas; genetic screening; hereditary neoplasia; multiple endocrine neoplasia type 1; pituitary adenoma

Year:  2011        PMID: 30290451     DOI: 10.1586/eem.10.87

Source DB:  PubMed          Journal:  Expert Rev Endocrinol Metab        ISSN: 1744-6651


  3 in total

1.  Clinical Relevance of Genetic Analysis in Patients With Pituitary Adenomas: A Systematic Review.

Authors:  Medard F M van den Broek; Bernadette P M van Nesselrooij; Annemarie A Verrijn Stuart; Rachel S van Leeuwaarde; Gerlof D Valk
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-10       Impact factor: 5.555

Review 2.  Clinical and genetic aspects of familial isolated pituitary adenomas.

Authors:  Vladimir Vasilev; Adrian Daly; Luciana Naves; Sabina Zacharieva; Albert Beckers
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

3.  A consensus on the diagnosis and treatment of acromegaly complications.

Authors:  S Melmed; F F Casanueva; A Klibanski; M D Bronstein; P Chanson; S W Lamberts; C J Strasburger; J A H Wass; A Giustina
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.